NATIONAL HEALTHCARE CORP (NHC) Stock Fundamental Analysis
USA - NYSEARCA:NHC - US6359061008 - Common Stock
128.12 USD
+1.5 (+1.18%)
128.12 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to NHC. NHC was compared to 100 industry peers in the Health Care Providers & Services industry. NHC scores excellent on profitability, but there are some minor concerns on its financial health. NHC is valued correctly, but it does not seem to be growing. Finally NHC also has an excellent dividend rating. These ratings would make NHC suitable for dividend investing!
1. Profitability
1.1 Basic Checks
In the past year NHC was profitable.
In the past year NHC had a positive cash flow from operations.
NHC had positive earnings in each of the past 5 years.
In the past 5 years NHC always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 6.71%, NHC belongs to the best of the industry, outperforming 87.00% of the companies in the same industry.
NHC has a Return On Equity of 10.26%. This is in the better half of the industry: NHC outperforms 74.00% of its industry peers.
NHC has a better Return On Invested Capital (6.69%) than 67.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NHC is significantly below the industry average of 9.40%.
The last Return On Invested Capital (6.69%) for NHC is above the 3 year average (3.68%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROIC | 6.69% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
1.3 Margins
The Profit Margin of NHC (7.19%) is better than 86.00% of its industry peers.
In the last couple of years the Profit Margin of NHC has grown nicely.
The Operating Margin of NHC (7.99%) is better than 73.00% of its industry peers.
NHC's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 38.11%, NHC is doing good in the industry, outperforming 66.00% of the companies in the same industry.
In the last couple of years the Gross Margin of NHC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% |
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
2. Health
2.1 Basic Checks
NHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NHC has more shares outstanding
The number of shares outstanding for NHC has been increased compared to 5 years ago.
The debt/assets ratio for NHC is higher compared to a year ago.
2.2 Solvency
NHC has an Altman-Z score of 4.24. This indicates that NHC is financially healthy and has little risk of bankruptcy at the moment.
NHC has a better Altman-Z score (4.24) than 77.00% of its industry peers.
NHC has a debt to FCF ratio of 0.93. This is a very positive value and a sign of high solvency as it would only need 0.93 years to pay back of all of its debts.
NHC has a better Debt to FCF ratio (0.93) than 91.00% of its industry peers.
NHC has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.10, NHC is in the better half of the industry, outperforming 76.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Altman-Z | 4.24 |
ROIC/WACC0.74
WACC9.02%
2.3 Liquidity
NHC has a Current Ratio of 1.72. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NHC (1.72) is better than 66.00% of its industry peers.
NHC has a Quick Ratio of 1.69. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NHC (1.69) is better than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 13.19% over the past year.
NHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.03% yearly.
Looking at the last year, NHC shows a very strong growth in Revenue. The Revenue has grown by 22.82%.
NHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.58% yearly.
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 19.09, which indicates a rather expensive current valuation of NHC.
Compared to the rest of the industry, the Price/Earnings ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 69.00% of the companies listed in the same industry.
NHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.09 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 67.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, NHC is valued a bit cheaper than 71.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.7 | ||
| EV/EBITDA | 10.53 |
4.3 Compensation for Growth
The excellent profitability rating of NHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.38
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NHC has a Yearly Dividend Yield of 2.02%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.57, NHC pays a better dividend. On top of this NHC pays more dividend than 90.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, NHC has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
5.2 History
The dividend of NHC has a limited annual growth rate of 3.30%.
NHC has been paying a dividend for at least 10 years, so it has a reliable track record.
NHC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
35.96% of the earnings are spent on dividend by NHC. This is a low number and sustainable payout ratio.
NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP35.96%
EPS Next 2YN/A
EPS Next 3YN/A
128.12
+1.5 (+1.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners59.33%
Inst Owner Change5.56%
Ins Owners7.03%
Ins Owner Change0.55%
Market Cap1.99B
Revenue(TTM)1.46B
Net Income(TTM)104.80M
Analysts60
Price TargetN/A
Short Float %2.31%
Short Ratio4.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP35.96%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.09 | ||
| Fwd PE | N/A | ||
| P/S | 1.36 | ||
| P/FCF | 16.7 | ||
| P/OCF | 13.32 | ||
| P/B | 1.94 | ||
| P/tB | 2.39 | ||
| EV/EBITDA | 10.53 |
EPS(TTM)6.71
EY5.24%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.67
FCFY5.99%
OCF(TTM)9.62
OCFY7.51%
SpS94.07
BVpS65.93
TBVpS53.65
PEG (NY)N/A
PEG (5Y)2.38
Graham Number99.77
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROCE | 9.01% | ||
| ROIC | 6.69% | ||
| ROICexc | 8.35% | ||
| ROICexgc | 10.23% | ||
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% | ||
| FCFM | 8.16% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score4
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Debt/EBITDA | 0.64 | ||
| Cap/Depr | 68.45% | ||
| Cap/Sales | 2.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.81% | ||
| Profit Quality | 113.47% | ||
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.24 |
F-Score4
WACC9.02%
ROIC/WACC0.74
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.08%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.85%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y136.11%
OCF growth 3Y19.81%
OCF growth 5Y1.4%
NATIONAL HEALTHCARE CORP / NHC FAQ
What is the fundamental rating for NHC stock?
ChartMill assigns a fundamental rating of 6 / 10 to NHC.
What is the valuation status of NATIONAL HEALTHCARE CORP (NHC) stock?
ChartMill assigns a valuation rating of 4 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Fairly Valued.
How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?
NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.
What are the PE and PB ratios of NATIONAL HEALTHCARE CORP (NHC) stock?
The Price/Earnings (PE) ratio for NATIONAL HEALTHCARE CORP (NHC) is 19.09 and the Price/Book (PB) ratio is 1.94.
How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?
The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 35.96%.